Previous studies have found that PCK1 is downregulated in hepatocellular carcinoma (HCC), and KO of PCK1 enhances the proliferation and metastasis of HCC in vitro and in vivo (17–21). This evidence concerns the gene PCK1 and hepatocellular carcinoma.